nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ALB—Prednisone—ankylosing spondylitis	0.141	0.179	CbGbCtD
Pethidine—CYP2C19—Prednisone—ankylosing spondylitis	0.0915	0.116	CbGbCtD
Pethidine—CYP2B6—Dexamethasone—ankylosing spondylitis	0.0899	0.114	CbGbCtD
Pethidine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.073	0.0926	CbGbCtD
Pethidine—ALB—Methotrexate—ankylosing spondylitis	0.0708	0.0898	CbGbCtD
Pethidine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0571	0.0725	CbGbCtD
Pethidine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0553	0.0702	CbGbCtD
Pethidine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0475	0.0602	CbGbCtD
Pethidine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0468	0.0594	CbGbCtD
Pethidine—CYP3A4—Prednisone—ankylosing spondylitis	0.0442	0.0561	CbGbCtD
Pethidine—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0434	0.0551	CbGbCtD
Pethidine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0276	0.035	CbGbCtD
Pethidine—Fibrosis—Methotrexate—ankylosing spondylitis	0.00512	0.0242	CcSEcCtD
Pethidine—Withdrawal syndrome—Prednisone—ankylosing spondylitis	0.00419	0.0198	CcSEcCtD
Pethidine—Anuria—Methotrexate—ankylosing spondylitis	0.00419	0.0198	CcSEcCtD
Pethidine—Neurotoxicity—Methotrexate—ankylosing spondylitis	0.00378	0.0178	CcSEcCtD
Pethidine—Mydriasis—Prednisolone—ankylosing spondylitis	0.00302	0.0143	CcSEcCtD
Pethidine—Paralysis—Methotrexate—ankylosing spondylitis	0.00211	0.00995	CcSEcCtD
Pethidine—Euphoric mood—Prednisolone—ankylosing spondylitis	0.00207	0.00978	CcSEcCtD
Pethidine—Delirium—Prednisone—ankylosing spondylitis	0.00204	0.00961	CcSEcCtD
Pethidine—Euphoric mood—Triamcinolone—ankylosing spondylitis	0.0019	0.00899	CcSEcCtD
Pethidine—Euphoric mood—Methylprednisolone—ankylosing spondylitis	0.0019	0.00897	CcSEcCtD
Pethidine—Visual disturbance—Prednisolone—ankylosing spondylitis	0.00185	0.00872	CcSEcCtD
Pethidine—Euphoric mood—Dexamethasone—ankylosing spondylitis	0.00173	0.00816	CcSEcCtD
Pethidine—Euphoric mood—Betamethasone—ankylosing spondylitis	0.00173	0.00816	CcSEcCtD
Pethidine—Affect lability—Prednisolone—ankylosing spondylitis	0.00172	0.00813	CcSEcCtD
Pethidine—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00166	0.00785	CcSEcCtD
Pethidine—Mood swings—Prednisolone—ankylosing spondylitis	0.00166	0.00782	CcSEcCtD
Pethidine—Affect lability—Triamcinolone—ankylosing spondylitis	0.00158	0.00748	CcSEcCtD
Pethidine—Affect lability—Methylprednisolone—ankylosing spondylitis	0.00158	0.00746	CcSEcCtD
Pethidine—Psychotic disorder—Methylprednisolone—ankylosing spondylitis	0.00157	0.0074	CcSEcCtD
Pethidine—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.00154	0.00727	CcSEcCtD
Pethidine—Visual disturbance—Betamethasone—ankylosing spondylitis	0.00154	0.00727	CcSEcCtD
Pethidine—Irritability—Methylprednisolone—ankylosing spondylitis	0.00153	0.00723	CcSEcCtD
Pethidine—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00153	0.00722	CcSEcCtD
Pethidine—Hyperkinesia—Prednisone—ankylosing spondylitis	0.00153	0.00721	CcSEcCtD
Pethidine—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00153	0.00721	CcSEcCtD
Pethidine—Mood swings—Triamcinolone—ankylosing spondylitis	0.00152	0.0072	CcSEcCtD
Pethidine—Mood swings—Methylprednisolone—ankylosing spondylitis	0.00152	0.00718	CcSEcCtD
Pethidine—Euphoric mood—Prednisone—ankylosing spondylitis	0.0015	0.0071	CcSEcCtD
Pethidine—Affect lability—Dexamethasone—ankylosing spondylitis	0.00144	0.00678	CcSEcCtD
Pethidine—Affect lability—Betamethasone—ankylosing spondylitis	0.00144	0.00678	CcSEcCtD
Pethidine—Psychotic disorder—Betamethasone—ankylosing spondylitis	0.00143	0.00673	CcSEcCtD
Pethidine—Psychotic disorder—Dexamethasone—ankylosing spondylitis	0.00143	0.00673	CcSEcCtD
Pethidine—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.00141	0.00667	CcSEcCtD
Pethidine—Irritability—Dexamethasone—ankylosing spondylitis	0.00139	0.00658	CcSEcCtD
Pethidine—Irritability—Betamethasone—ankylosing spondylitis	0.00139	0.00658	CcSEcCtD
Pethidine—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00139	0.00655	CcSEcCtD
Pethidine—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00139	0.00655	CcSEcCtD
Pethidine—Mood swings—Dexamethasone—ankylosing spondylitis	0.00138	0.00653	CcSEcCtD
Pethidine—Mood swings—Betamethasone—ankylosing spondylitis	0.00138	0.00653	CcSEcCtD
Pethidine—Coma—Methotrexate—ankylosing spondylitis	0.00134	0.00631	CcSEcCtD
Pethidine—Affect lability—Prednisone—ankylosing spondylitis	0.00125	0.00591	CcSEcCtD
Pethidine—Psychotic disorder—Prednisone—ankylosing spondylitis	0.00124	0.00586	CcSEcCtD
Pethidine—Bradycardia—Prednisolone—ankylosing spondylitis	0.00123	0.00582	CcSEcCtD
Pethidine—Irritability—Prednisone—ankylosing spondylitis	0.00121	0.00573	CcSEcCtD
Pethidine—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00121	0.00571	CcSEcCtD
Pethidine—Mood swings—Prednisone—ankylosing spondylitis	0.0012	0.00569	CcSEcCtD
Pethidine—Sweating—Methylprednisolone—ankylosing spondylitis	0.00119	0.0056	CcSEcCtD
Pethidine—Visual impairment—Prednisolone—ankylosing spondylitis	0.00117	0.00551	CcSEcCtD
Pethidine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00113	0.00535	CcSEcCtD
Pethidine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00113	0.00534	CcSEcCtD
Pethidine—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00112	0.00529	CcSEcCtD
Pethidine—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00111	0.00522	CcSEcCtD
Pethidine—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00107	0.00505	CcSEcCtD
Pethidine—Erythema—Prednisolone—ankylosing spondylitis	0.00105	0.00497	CcSEcCtD
Pethidine—Bradycardia—Betamethasone—ankylosing spondylitis	0.00103	0.00485	CcSEcCtD
Pethidine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00103	0.00485	CcSEcCtD
Pethidine—Irritability—Methotrexate—ankylosing spondylitis	0.00101	0.00479	CcSEcCtD
Pethidine—Mood swings—Methotrexate—ankylosing spondylitis	0.00101	0.00475	CcSEcCtD
Pethidine—Hallucination—Dexamethasone—ankylosing spondylitis	0.001	0.00474	CcSEcCtD
Pethidine—Hallucination—Betamethasone—ankylosing spondylitis	0.001	0.00474	CcSEcCtD
Pethidine—Visual impairment—Dexamethasone—ankylosing spondylitis	0.000973	0.00459	CcSEcCtD
Pethidine—Visual impairment—Betamethasone—ankylosing spondylitis	0.000973	0.00459	CcSEcCtD
Pethidine—Erythema—Triamcinolone—ankylosing spondylitis	0.000969	0.00457	CcSEcCtD
Pethidine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000967	0.00456	CcSEcCtD
Pethidine—Vertigo—Prednisolone—ankylosing spondylitis	0.000947	0.00447	CcSEcCtD
Pethidine—Syncope—Prednisolone—ankylosing spondylitis	0.000945	0.00446	CcSEcCtD
Pethidine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000926	0.00437	CcSEcCtD
Pethidine—Convulsion—Prednisolone—ankylosing spondylitis	0.000913	0.00431	CcSEcCtD
Pethidine—Hypertension—Prednisolone—ankylosing spondylitis	0.00091	0.00429	CcSEcCtD
Pethidine—Bradycardia—Prednisone—ankylosing spondylitis	0.000895	0.00423	CcSEcCtD
Pethidine—Erythema—Dexamethasone—ankylosing spondylitis	0.000879	0.00415	CcSEcCtD
Pethidine—Erythema—Betamethasone—ankylosing spondylitis	0.000879	0.00415	CcSEcCtD
Pethidine—Hallucination—Prednisone—ankylosing spondylitis	0.000875	0.00413	CcSEcCtD
Pethidine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000871	0.00411	CcSEcCtD
Pethidine—Syncope—Triamcinolone—ankylosing spondylitis	0.000869	0.0041	CcSEcCtD
Pethidine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000869	0.0041	CcSEcCtD
Pethidine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000867	0.00409	CcSEcCtD
Pethidine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00086	0.00406	CcSEcCtD
Pethidine—Oedema—Prednisolone—ankylosing spondylitis	0.00086	0.00406	CcSEcCtD
Pethidine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000852	0.00402	CcSEcCtD
Pethidine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00085	0.00401	CcSEcCtD
Pethidine—Shock—Prednisolone—ankylosing spondylitis	0.000846	0.00399	CcSEcCtD
Pethidine—Convulsion—Triamcinolone—ankylosing spondylitis	0.00084	0.00396	CcSEcCtD
Pethidine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000839	0.00396	CcSEcCtD
Pethidine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000838	0.00395	CcSEcCtD
Pethidine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000837	0.00395	CcSEcCtD
Pethidine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000835	0.00394	CcSEcCtD
Pethidine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000831	0.00392	CcSEcCtD
Pethidine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00082	0.00387	CcSEcCtD
Pethidine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000819	0.00387	CcSEcCtD
Pethidine—Flushing—Prednisone—ankylosing spondylitis	0.000816	0.00385	CcSEcCtD
Pethidine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000807	0.00381	CcSEcCtD
Pethidine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000796	0.00376	CcSEcCtD
Pethidine—Oedema—Triamcinolone—ankylosing spondylitis	0.000791	0.00373	CcSEcCtD
Pethidine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000791	0.00373	CcSEcCtD
Pethidine—Vertigo—Dexamethasone—ankylosing spondylitis	0.00079	0.00373	CcSEcCtD
Pethidine—Vertigo—Betamethasone—ankylosing spondylitis	0.00079	0.00373	CcSEcCtD
Pethidine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000789	0.00372	CcSEcCtD
Pethidine—Syncope—Betamethasone—ankylosing spondylitis	0.000788	0.00372	CcSEcCtD
Pethidine—Syncope—Dexamethasone—ankylosing spondylitis	0.000788	0.00372	CcSEcCtD
Pethidine—Sweating—Methotrexate—ankylosing spondylitis	0.000785	0.00371	CcSEcCtD
Pethidine—Shock—Triamcinolone—ankylosing spondylitis	0.000778	0.00367	CcSEcCtD
Pethidine—Insomnia—Prednisolone—ankylosing spondylitis	0.000778	0.00367	CcSEcCtD
Pethidine—Shock—Methylprednisolone—ankylosing spondylitis	0.000776	0.00366	CcSEcCtD
Pethidine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000773	0.00365	CcSEcCtD
Pethidine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000773	0.00365	CcSEcCtD
Pethidine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000772	0.00364	CcSEcCtD
Pethidine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00077	0.00364	CcSEcCtD
Pethidine—Erythema—Prednisone—ankylosing spondylitis	0.000766	0.00361	CcSEcCtD
Pethidine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000765	0.00361	CcSEcCtD
Pethidine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000763	0.0036	CcSEcCtD
Pethidine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000762	0.0036	CcSEcCtD
Pethidine—Convulsion—Betamethasone—ankylosing spondylitis	0.000762	0.0036	CcSEcCtD
Pethidine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000759	0.00358	CcSEcCtD
Pethidine—Hypertension—Betamethasone—ankylosing spondylitis	0.000759	0.00358	CcSEcCtD
Pethidine—Anxiety—Betamethasone—ankylosing spondylitis	0.000746	0.00352	CcSEcCtD
Pethidine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000746	0.00352	CcSEcCtD
Pethidine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000737	0.00348	CcSEcCtD
Pethidine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000718	0.00339	CcSEcCtD
Pethidine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000718	0.00339	CcSEcCtD
Pethidine—Oedema—Dexamethasone—ankylosing spondylitis	0.000718	0.00339	CcSEcCtD
Pethidine—Oedema—Betamethasone—ankylosing spondylitis	0.000718	0.00339	CcSEcCtD
Pethidine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000715	0.00338	CcSEcCtD
Pethidine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000714	0.00337	CcSEcCtD
Pethidine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000709	0.00335	CcSEcCtD
Pethidine—Visual impairment—Methotrexate—ankylosing spondylitis	0.000708	0.00334	CcSEcCtD
Pethidine—Shock—Betamethasone—ankylosing spondylitis	0.000706	0.00333	CcSEcCtD
Pethidine—Shock—Dexamethasone—ankylosing spondylitis	0.000706	0.00333	CcSEcCtD
Pethidine—Agitation—Prednisone—ankylosing spondylitis	0.000704	0.00332	CcSEcCtD
Pethidine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.0007	0.00331	CcSEcCtD
Pethidine—Tachycardia—Betamethasone—ankylosing spondylitis	0.0007	0.00331	CcSEcCtD
Pethidine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000694	0.00327	CcSEcCtD
Pethidine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000694	0.00327	CcSEcCtD
Pethidine—Vertigo—Prednisone—ankylosing spondylitis	0.000688	0.00325	CcSEcCtD
Pethidine—Syncope—Prednisone—ankylosing spondylitis	0.000687	0.00324	CcSEcCtD
Pethidine—Anorexia—Betamethasone—ankylosing spondylitis	0.000684	0.00323	CcSEcCtD
Pethidine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000684	0.00323	CcSEcCtD
Pethidine—Urticaria—Prednisolone—ankylosing spondylitis	0.000683	0.00322	CcSEcCtD
Pethidine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000673	0.00318	CcSEcCtD
Pethidine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000671	0.00317	CcSEcCtD
Pethidine—Hypotension—Betamethasone—ankylosing spondylitis	0.000671	0.00317	CcSEcCtD
Pethidine—Convulsion—Prednisone—ankylosing spondylitis	0.000663	0.00313	CcSEcCtD
Pethidine—Hypertension—Prednisone—ankylosing spondylitis	0.000661	0.00312	CcSEcCtD
Pethidine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000652	0.00308	CcSEcCtD
Pethidine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00065	0.00307	CcSEcCtD
Pethidine—Anxiety—Prednisone—ankylosing spondylitis	0.00065	0.00307	CcSEcCtD
Pethidine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000649	0.00306	CcSEcCtD
Pethidine—Insomnia—Betamethasone—ankylosing spondylitis	0.000649	0.00306	CcSEcCtD
Pethidine—Erythema—Methotrexate—ankylosing spondylitis	0.00064	0.00302	CcSEcCtD
Pethidine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000634	0.00299	CcSEcCtD
Pethidine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000628	0.00297	CcSEcCtD
Pethidine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000627	0.00296	CcSEcCtD
Pethidine—Oedema—Prednisone—ankylosing spondylitis	0.000625	0.00295	CcSEcCtD
Pethidine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000625	0.00295	CcSEcCtD
Pethidine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000624	0.00294	CcSEcCtD
Pethidine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000624	0.00294	CcSEcCtD
Pethidine—Shock—Prednisone—ankylosing spondylitis	0.000615	0.0029	CcSEcCtD
Pethidine—Tachycardia—Prednisone—ankylosing spondylitis	0.00061	0.00288	CcSEcCtD
Pethidine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000604	0.00285	CcSEcCtD
Pethidine—Anorexia—Prednisone—ankylosing spondylitis	0.000596	0.00281	CcSEcCtD
Pethidine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000591	0.00279	CcSEcCtD
Pethidine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000591	0.00279	CcSEcCtD
Pethidine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000583	0.00275	CcSEcCtD
Pethidine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000581	0.00274	CcSEcCtD
Pethidine—Vertigo—Methotrexate—ankylosing spondylitis	0.000575	0.00271	CcSEcCtD
Pethidine—Urticaria—Betamethasone—ankylosing spondylitis	0.00057	0.00269	CcSEcCtD
Pethidine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00057	0.00269	CcSEcCtD
Pethidine—Dizziness—Prednisolone—ankylosing spondylitis	0.000569	0.00268	CcSEcCtD
Pethidine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000567	0.00268	CcSEcCtD
Pethidine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000566	0.00267	CcSEcCtD
Pethidine—Insomnia—Prednisone—ankylosing spondylitis	0.000565	0.00267	CcSEcCtD
Pethidine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00056	0.00264	CcSEcCtD
Pethidine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000558	0.00264	CcSEcCtD
Pethidine—Convulsion—Methotrexate—ankylosing spondylitis	0.000554	0.00262	CcSEcCtD
Pethidine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000543	0.00256	CcSEcCtD
Pethidine—Rash—Prednisolone—ankylosing spondylitis	0.000542	0.00256	CcSEcCtD
Pethidine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000542	0.00256	CcSEcCtD
Pethidine—Headache—Prednisolone—ankylosing spondylitis	0.000539	0.00254	CcSEcCtD
Pethidine—Constipation—Prednisone—ankylosing spondylitis	0.000534	0.00252	CcSEcCtD
Pethidine—Confusional state—Methotrexate—ankylosing spondylitis	0.000527	0.00249	CcSEcCtD
Pethidine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000523	0.00247	CcSEcCtD
Pethidine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000522	0.00247	CcSEcCtD
Pethidine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000522	0.00246	CcSEcCtD
Pethidine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000515	0.00243	CcSEcCtD
Pethidine—Asthenia—Betamethasone—ankylosing spondylitis	0.000515	0.00243	CcSEcCtD
Pethidine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000515	0.00243	CcSEcCtD
Pethidine—Nausea—Prednisolone—ankylosing spondylitis	0.000511	0.00241	CcSEcCtD
Pethidine—Pruritus—Betamethasone—ankylosing spondylitis	0.000508	0.0024	CcSEcCtD
Pethidine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000508	0.0024	CcSEcCtD
Pethidine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000505	0.00238	CcSEcCtD
Pethidine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000503	0.00237	CcSEcCtD
Pethidine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000502	0.00237	CcSEcCtD
Pethidine—Rash—Triamcinolone—ankylosing spondylitis	0.000499	0.00235	CcSEcCtD
Pethidine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000498	0.00235	CcSEcCtD
Pethidine—Anorexia—Methotrexate—ankylosing spondylitis	0.000498	0.00235	CcSEcCtD
Pethidine—Rash—Methylprednisolone—ankylosing spondylitis	0.000498	0.00235	CcSEcCtD
Pethidine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000497	0.00235	CcSEcCtD
Pethidine—Urticaria—Prednisone—ankylosing spondylitis	0.000496	0.00234	CcSEcCtD
Pethidine—Headache—Triamcinolone—ankylosing spondylitis	0.000495	0.00234	CcSEcCtD
Pethidine—Headache—Methylprednisolone—ankylosing spondylitis	0.000494	0.00233	CcSEcCtD
Pethidine—Hypotension—Methotrexate—ankylosing spondylitis	0.000488	0.0023	CcSEcCtD
Pethidine—Dizziness—Betamethasone—ankylosing spondylitis	0.000475	0.00224	CcSEcCtD
Pethidine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000475	0.00224	CcSEcCtD
Pethidine—Insomnia—Methotrexate—ankylosing spondylitis	0.000472	0.00223	CcSEcCtD
Pethidine—Nausea—Triamcinolone—ankylosing spondylitis	0.00047	0.00222	CcSEcCtD
Pethidine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000469	0.00221	CcSEcCtD
Pethidine—Somnolence—Methotrexate—ankylosing spondylitis	0.000464	0.00219	CcSEcCtD
Pethidine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00046	0.00217	CcSEcCtD
Pethidine—Vomiting—Betamethasone—ankylosing spondylitis	0.000456	0.00215	CcSEcCtD
Pethidine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000456	0.00215	CcSEcCtD
Pethidine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000454	0.00214	CcSEcCtD
Pethidine—Rash—Dexamethasone—ankylosing spondylitis	0.000452	0.00214	CcSEcCtD
Pethidine—Rash—Betamethasone—ankylosing spondylitis	0.000452	0.00214	CcSEcCtD
Pethidine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000452	0.00213	CcSEcCtD
Pethidine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000452	0.00213	CcSEcCtD
Pethidine—Headache—Dexamethasone—ankylosing spondylitis	0.00045	0.00212	CcSEcCtD
Pethidine—Headache—Betamethasone—ankylosing spondylitis	0.00045	0.00212	CcSEcCtD
Pethidine—Asthenia—Prednisone—ankylosing spondylitis	0.000448	0.00212	CcSEcCtD
Pethidine—Pruritus—Prednisone—ankylosing spondylitis	0.000442	0.00209	CcSEcCtD
Pethidine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00043	0.00203	CcSEcCtD
Pethidine—Nausea—Dexamethasone—ankylosing spondylitis	0.000426	0.00201	CcSEcCtD
Pethidine—Nausea—Betamethasone—ankylosing spondylitis	0.000426	0.00201	CcSEcCtD
Pethidine—Urticaria—Methotrexate—ankylosing spondylitis	0.000415	0.00196	CcSEcCtD
Pethidine—Dizziness—Prednisone—ankylosing spondylitis	0.000413	0.00195	CcSEcCtD
Pethidine—Vomiting—Prednisone—ankylosing spondylitis	0.000397	0.00188	CcSEcCtD
Pethidine—Rash—Prednisone—ankylosing spondylitis	0.000394	0.00186	CcSEcCtD
Pethidine—Dermatitis—Prednisone—ankylosing spondylitis	0.000394	0.00186	CcSEcCtD
Pethidine—Headache—Prednisone—ankylosing spondylitis	0.000391	0.00185	CcSEcCtD
Pethidine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000385	0.00182	CcSEcCtD
Pethidine—Asthenia—Methotrexate—ankylosing spondylitis	0.000375	0.00177	CcSEcCtD
Pethidine—Nausea—Prednisone—ankylosing spondylitis	0.000371	0.00175	CcSEcCtD
Pethidine—Pruritus—Methotrexate—ankylosing spondylitis	0.000369	0.00174	CcSEcCtD
Pethidine—Dizziness—Methotrexate—ankylosing spondylitis	0.000345	0.00163	CcSEcCtD
Pethidine—Vomiting—Methotrexate—ankylosing spondylitis	0.000332	0.00157	CcSEcCtD
Pethidine—Rash—Methotrexate—ankylosing spondylitis	0.000329	0.00155	CcSEcCtD
Pethidine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000329	0.00155	CcSEcCtD
Pethidine—Headache—Methotrexate—ankylosing spondylitis	0.000327	0.00154	CcSEcCtD
Pethidine—Nausea—Methotrexate—ankylosing spondylitis	0.00031	0.00146	CcSEcCtD
